InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2019 - 2026)
InMed Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $4199.0 for Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments rose 56.8% year-over-year to $4199.0; the TTM value through Dec 2025 reached $43424.0, down 3.0%, while the annual FY2025 figure was $42270.0, 0.45% changed from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $4199.0 at InMed Pharmaceuticals, down from $20957.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $21324.0 in Q3 2024 and troughed at -$431.0 in Q2 2024.
- A 3-year average of $12167.6 and a median of $16037.0 in 2025 define the central range for Change in Acquisitions & Divestments.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 617.63% in 2025 and fell as far as 24.34% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $21317.0 in 2023, then crashed by 87.44% to $2678.0 in 2024, then soared by 56.8% to $4199.0 in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for INM at $4199.0 in Q4 2025, $20957.0 in Q3 2025, and $2231.0 in Q2 2025.